Therapeutic strategies to target HIF include the use of small molecule inhibitors that prevent HIF stabilization or dimerization, as well as agents that inhibit the downstream effects of HIF activation, such as VEGF inhibitors. Gene therapy approaches that downregulate HIF expression or function are also being explored.
